Selection of a muramyl peptide based on its lack of activation of nuclear factor-kappa B as a potential adjuvant for AIDS vaccines. [electronic resource]
Producer: 19921210Description: 188-93 p. digitalISSN:- 0009-9104
- Acetylmuramyl-Alanyl-Isoglutamine -- chemistry
- Acquired Immunodeficiency Syndrome -- therapy
- Adjuvants, Immunologic
- Animals
- Antioxidants -- pharmacology
- Base Sequence
- Cell Line
- Gene Expression
- Humans
- In Vitro Techniques
- Interleukin-8 -- genetics
- Mice
- Molecular Sequence Data
- NF-kappa B -- metabolism
- Oligodeoxyribonucleotides -- chemistry
- Reactive Oxygen Species -- metabolism
- Structure-Activity Relationship
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.